Azerbaijan vs Ghana: The number of people with susceptibility test result for rifampicin
Azerbaijan
96.11
in 2021
Ghana
96.1
in 2021
Azerbaijan rank
47th
Ghana rank
49th
The number of people with susceptibility test result for rifampicin over time
- Azerbaijan
- Ghana
How they compare
Azerbaijan currently reports 96.11 against 96.1 in Ghana, a difference of 0.01.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Ghana ahead.
Azerbaijan ranks 47th and Ghana ranks 49th of 146 countries.
Across the 2 decades both report, Azerbaijan averaged higher in 1 and Ghana in 1.
Head to head by decade
| Decade | Azerbaijan | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 99.09 | 97.71 | 1.38 | Azerbaijan |
| 2020s | 94.83 | 98.05 | 3.23 | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Azerbaijan or Ghana?
- Azerbaijan, at 96.11 against 96.1 in Ghana as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Azerbaijan and Ghana?
- 0.01, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Ghana?
- 5 years are reported by both, from 2017 to 2021.
- How do Azerbaijan and Ghana rank globally for the number of people with susceptibility test result for rifampicin?
- Azerbaijan ranks 47th and Ghana ranks 49th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.